Fundz

Insitro Appoints Hideo Makimura as Chief Medical Officer

PRIVATESep 08, 2026

Position

Chief Medical Officer

Company

Insitro

Hideo Makimura
San FranciscoBiotechnologyHealth CareTherapeutics

Description

insitro has appointed Hideo Makimura as Chief Medical Officer, effective Sept. 14. He will lead clinical development strategy as the company prepares for first-in-human trials.

Quick answer

Insitro Appoints Hideo Makimura as Chief Medical Officer (September 8, 2026). Insitro is based in San Francisco, California, United States.

Who is the new Chief Medical Officer at Insitro?
Insitro named Hideo Makimura Chief Medical Officer, announced September 8, 2026.
What did Insitro announce on September 8, 2026?
insitro has appointed Hideo Makimura as Chief Medical Officer, effective Sept. 14. He will lead clinical development strategy as the company prepares for first-in-human trials.
What does Insitro do?
Insitro is an AI therapeutics company focused on drug discovery and development.
Where is Insitro based?
Insitro is based in San Francisco, California, United States.
Which similar companies made leadership changes around the same time?
Prilenia (September 8, 2026), Abivax (September 7, 2026), Novocure (September 9, 2026) and Neurizon Therapeutics (September 7, 2026) also announced leadership changes within 45 days of Insitro.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Insitro, and when

A new leader at Insitro brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Insitro raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Insitro, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Insitro. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Insitro

Location

279 East Grand Avenue, Suite 200

San Francisco, California, United States

About

Insitro is an AI therapeutics company focused on drug discovery and development. The company utilizes machine learning techniques to enhance and expedite the process of pharmaceutical research. Insitro aims to transform the way drugs are discovered and developed, improving outcomes in healthcare. It has garnered respect in the biotech industry for its innovative approach.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Insitro changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Company Contact
Likely contact at this company
••••••••@••••••••

See Company Contact's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Insitro's next move

Learn about Strategic plan

Insitro changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.